23:21 , Apr 11, 2019 |  BC Extra  |  Company News

Management tracks: Prime, Flexion, NodThera, Imara

PBM Prime Therapeutics LLC (Eagan, Minn.) hired Kenneth Paulus as president and CEO, effective May 7. Paulus is an executive adviser at Water Street Healthcare Partners. In 2005-15, Paulus held leadership roles at Minneapolis-based non-profit...
00:15 , Jun 22, 2016 |  BC Extra  |  Financial News

Wu joins Carlyle Group

The Carlyle Group (NASDAQ:CG) named Jesse Wu senior advisor to its Asia buyout team. Wu was chairman of the China unit of Johnson & Johnson (NYSE:JNJ)....
07:00 , May 9, 2016 |  BioCentury  |  Finance

ven and now

Strategic LPs once again dominate the second fund from venBio LLC, even though none of the first fund's M&A exits went to an LP. The firm's Global Strategic Fund II closed last week at $315...
01:15 , May 6, 2015 |  BC Extra  |  Financial News

Financial tracks

Alternative asset management firm The Carlyle Group (NASDAQ:CG) named Jose Almeida an operating executive in its global heathcare group. Almeida was chairman, president and CEO of Covidien. Jason Kantor resigned as a managing director and...
07:00 , Sep 1, 2014 |  BC Week In Review  |  Company News

Astute, Ortho-Clinical Diagnostics deal

Astute granted Ortho-Clinical Diagnostics exclusive, commercialization rights to the NephroCheck test and the Astute140 Meter in 11 countries in the EU and the U.S. The deal covers Austria, Belgium, France, Germany, Italy, Luxemburg, the Netherlands,...
07:00 , Aug 18, 2014 |  BC Week In Review  |  Company News

J&J, The Carlyle Group deal

In June, Johnson & Johnson said asset manager The Carlyle Group completed the acquisition of the pharma's Ortho-Clinical Diagnostics business for about $4 billion. The pharma said the business, which generated 2013 net sales of...
07:00 , Apr 7, 2014 |  BC Week In Review  |  Company News

J&J, The Carlyle Group deal

Johnson & Johnson accepted a binding offer from asset manager The Carlyle Group to acquire the pharma's Ortho-Clinical Diagnostics business for $4.2 billion in cash. The pharma does not break out sales for the business,...
23:42 , Mar 31, 2014 |  BC Extra  |  Company News

Carlyle Group to acquire J&J's Ortho-Clinical Diagnostics business

Johnson & Johnson (NYSE:JNJ) accepted a binding offer from asset manager The Carlyle Group to acquire the pharma's Ortho-Clinical Diagnostics business for $4.2 billion in cash. The pharma does not break out sales for the...
07:00 , Mar 10, 2014 |  BC Week In Review  |  Company News

J&J management update

Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J.   Business: Pharmaceuticals   Hired: Martin Madaus as CEO and chairman of Johnson & Johnson's Ortho-Clinical Diagnostics Inc. business, a newly created position, effective when The Carlyle Group...
08:00 , Jan 20, 2014 |  BC Week In Review  |  Company News

J&J, The Carlyle Group deal

Johnson & Johnson received a binding offer from asset manager The Carlyle Group to acquire the pharma's Ortho-Clinical Diagnostics business for $4.2 billion. The business markets products to screen for, diagnose and monitor diseases for...